10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers
The pharmaceutical industry is one of the most interesting sectors to invest in.
Ani Pharmaceuticals Inc (ANIP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 603,800 | $38,449,984 | -38% | 1% |
| 2. | Deep Track Capital David Kroin | 466,089 | $29,680,548 | -44% | 0.88% |
| 3. | Tang Capital Management Kevin C. Tang | 450,000 | $28,656,000 | +200% | 2.91% |
| 4. | Citadel Investment Group Ken Griffin | 368,339 | $23,455,828 | +211% | 0% |
| 5. | Millennium Management Israel Englander | 230,079 | $14,651,431 | +1006% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.69 | 7,224 | 169,650 | 2022-03-21 | Filing | ||
| $27.76 | 5,000 | 53,388 | 2022-03-21 | Filing | ||
| $27.87 | 5,000 | 393,226 | 2022-03-21 | Filing | ||
| $27.15 | 5,000 | 388,226 | 2022-03-18 | Filing | ||
| $27.65 | 5,000 | 5,000 | 2022-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.82 | 250 | Officer | 56,738 | 2024-09-13 | Filing | |
| $59.62 | 250 | Officer | 56,988 | 2024-08-13 | Filing | |
| $62.00 | 2,743 | Officer, Director | 632,620 | 2024-07-18 | Filing | |
| $63.16 | 14,257 | Officer, Director | 635,363 | 2024-07-17 | Filing | |
| $64.27 | 22,000 | Officer, Director | 649,620 | 2024-07-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,524,893 | $139,222,601 | 0% | |
| 2. | 1,288,972 | $71,073,916 | 0% | |
| 3. | 592,423 | $32,666,204 | 0% | |
| 4. | 591,731 | $32,627,756 | 0% | |
| 5. | 582,428 | $32,115,080 | 2.58% |
News See All
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Second Quarter 2024 Earnings Results Call. [Operator Instructions].
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript
ANI Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.937 EPS, expectations were $0.98.
11 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2023 Earnings Call Transcript
ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1, expectations were $0.8. ANI Pharmaceuticals, Inc.
13 Stocks That Will Double in 2024
Last year turned out to be wondrous for the US stock market as the S&P 500 gained over 25% compared to its 18% decline in the previous year.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the ANI Pharmaceuticals, Inc. Third Quarter 2023 Earnings Results Call. At this time, all participants are in a listen-only mode.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone. My name is Chelsea and I will be your conference operator.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2023 Earnings Call Transcript
Operator: Good day, everyone. And welcome to today’s ANI Pharmaceuticals Q1 2023 Earnings Call. At this time, all participants are in a listen-only mode.
11 Stocks Making Headlines After Earnings Reports
In this article, we will take a look at the 11 stocks making headlines after earnings reports.
Billionaire Hedge Funds
